NCT01188993

Brief Summary

The purpose of this study is to assess the concordance of therapeutic changes proposed after an early hemodynamic evaluation (hemodynamic profile) in septic shock patients using jointly the transpulmonary thermodilution technique and transesophageal echocardiography (TEE).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
153

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Jan 2011

Longer than P75 for phase_4

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 25, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 26, 2010

Completed
4 months until next milestone

Study Start

First participant enrolled

January 1, 2011

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2014

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2014

Completed
Last Updated

August 22, 2018

Status Verified

August 1, 2010

Enrollment Period

3 years

First QC Date

August 25, 2010

Last Update Submit

August 20, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • therapeutic procedure following the hemodynamic assessment

    Changes in therapy proposed after the hemodynamic assessment (hemodynamic profile) by each of the two tested methods: blood volume expansion (preload responsiveness), positive inotrope (cardiac dysfunction), vasopressor (vasoplegia), no change in ongoing therapy or dose tapering (inotropes or vasopressor).

    2 years

Secondary Outcomes (1)

  • efficacy and safety of therapeutic intervention

    2 years

Study Arms (2)

septic shock TPT then TEE

ACTIVE COMPARATOR

Group 1: Each patient will be assessed by both the transpulmonary thermodilution technique and transesophageal echocardiography (TEE)..

Combination Product: early septic shock

septic shock TEE then TPT

ACTIVE COMPARATOR

Goup 2: Each patient will be assessed by both transesophageal echocardiography (TEE) and the transpulmonary thermodilution technique.

Combination Product: early septic shock

Interventions

early septic shockCOMBINATION_PRODUCT

Each patient will be assessed by both the transpulmonary thermodilution and Transesophageal Echocardiography.

septic shock TEE then TPTseptic shock TPT then TEE

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ventilated patient in sinus rhythm with septic shock requiring a hemodynamic assessment

You may not qualify if:

  • \< 18 yr-old
  • pregnancy
  • contra-indication for TEE, non sinus rhythm, aplasia, prior participation to the study, hemodynamic assessment using any other technique than those tested in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Bordeaux UH

Bordeaux, 33 076, France

Location

Toulouse UH

Toulouse, 31 059, France

Location

Related Publications (1)

  • Vignon P, Begot E, Mari A, Silva S, Chimot L, Delour P, Vargas F, Filloux B, Vandroux D, Jabot J, Francois B, Pichon N, Clavel M, Levy B, Slama M, Riu-Poulenc B. Hemodynamic Assessment of Patients With Septic Shock Using Transpulmonary Thermodilution and Critical Care Echocardiography: A Comparative Study. Chest. 2018 Jan;153(1):55-64. doi: 10.1016/j.chest.2017.08.022. Epub 2017 Sep 1.

MeSH Terms

Conditions

Shock, Septic

Condition Hierarchy (Ancestors)

SepsisInfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsShock

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 25, 2010

First Posted

August 26, 2010

Study Start

January 1, 2011

Primary Completion

January 1, 2014

Study Completion

December 1, 2014

Last Updated

August 22, 2018

Record last verified: 2010-08

Locations